NASDAQ:CGEN
Compugen Ltd.
- Stock
locale
Israelmarket
STOCKSindustry
Biotechnologywebsite
cgen.comipo date
Aug 11, 2000
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antib...Show More
Earnings
Earnings Release in 9 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus